Cargando…

The predictive value of arterial stiffness on major adverse cardiovascular events in individuals with mildly impaired renal function

OBJECTIVES: Despite growing evidence that arterial stiffness has important predictive value for cardiovascular disease in patients with advanced stages of chronic kidney disease, the predictive significance of arterial stiffness in individuals with mildly impaired renal function has not been establi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Jie, Wang, Xiaona, Ye, Ping, Cao, Ruihua, Yang, Xu, Xiao, Wenkai, Zhang, Yun, Bai, Yongyi, Wu, Hongmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010075/ https://www.ncbi.nlm.nih.gov/pubmed/27621605 http://dx.doi.org/10.2147/CIA.S109009

Ejemplares similares

The association between Hepcidin and arterial stiffness in a community-dwelling population
por: Wang, Xiaona, et al.
Publicado: (2018)

Triglycerides are a predictive factor for arterial stiffness: a community-based 4.8-year prospective study
por: Wang, Xiaona, et al.
Publicado: (2016)

Peripheral arterial stiffness is associated with higher baseline plasma uric acid: A prospective cohort study
por: Ding, Xiaohan, et al.
Publicado: (2017)

A higher baseline plasma uric acid level is an independent predictor of arterial stiffness: A community-based prospective study
por: Ding, Xiao-Han, et al.
Publicado: (2017)

The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population
por: Zhu, Qiwei, et al.
Publicado: (2016)

Association of high-sensitivity cardiac troponin T with mortality and cardiovascular events in a community-based prospective study in Beijing
por: Xiao, Wenkai, et al.
Publicado: (2017)

High-Sensitivity Cardiac Troponin T Is a Risk Factor for Major Adverse Cardiovascular Events and All-Cause Mortality: A 9.5-Year Follow-Up Study
por: Wang, Xiaona, et al.
Publicado: (2021)

The Association of Homocysteine with Metabolic Syndrome in a Community-Dwelling Population: Homocysteine Might Be Concomitant with Metabolic Syndrome
por: Wang, Xiaona, et al.
Publicado: (2014)

Plasma Homocysteine Is Associated with Aortic Arterial Stiffness but not Wave Reflection in Chinese Hypertensive Subjects
por: Xiao, Wenkai, et al.
Publicado: (2014)

Risk of major adverse cardiovascular events in subjects with asymptomatic mild carotid artery stenosis
por: Kwon, Hyunwook, et al.
Publicado: (2018)

ADMA predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus undergoing coronary angiography
por: Heunisch, Fabian, et al.
Publicado: (2017)

Correlation between small and dense low‐density lipoprotein cholesterol and cardiovascular events in Beijing community population
por: Wang, Xiaona, et al.
Publicado: (2021)

Urine Albumin Excretion Is Associated with Cardiac Troponin T Detected with a Highly Sensitive Assay in a Community-Based Population
por: Xiao, Wenkai, et al.
Publicado: (2015)

Urinary cGMP predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus before exposure to contrast medium
por: Chaykovska, Lyubov, et al.
Publicado: (2018)

Pulmonary Artery Stiffness by Cardiac Magnetic Resonance Imaging Predicts Major Adverse Cardiovascular Events in patients with Chronic Obstructive Pulmonary Disease
por: Agoston-Coldea, Lucia, et al.
Publicado: (2018)

Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study
por: Hashemi Madani, Nahid, et al.
Publicado: (2020)

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
por: Mal, Kheraj, et al.
Publicado: (2020)

Prediabetes as a risk factor for major adverse cardiovascular events
por: Mando, Ramy, et al.
Publicado: (2021)

Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events
por: Gaist, David, et al.
Publicado: (2022)

Comparison of HEAR and HEART Scores for Major Adverse Cardiovascular Events
por: Uyan, Umut
Publicado: (2023)

Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment
por: Shin, Hong-Joon, et al.
Publicado: (2023)

Major Adverse Cardiovascular Events in Patients With Renal Cell Carcinoma Treated With Targeted Therapies
por: Chen, Dong-Yi, et al.
Publicado: (2022)

Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients
por: Peluso, Rosario, et al.
Publicado: (2018)

Association of EZSCAN Values with Arterial Stiffness in Individuals without Diabetes or Cardiovascular Disease
por: Zeng, Qiang, et al.
Publicado: (2014)

Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes
por: Regan, Jessica A., et al.
Publicado: (2023)

Heterogeneous plaque–lumen geometry is associated with major adverse cardiovascular events
por: Gu, Sophie Z, et al.
Publicado: (2023)

Olfactory impairment and the risk of major adverse cardiovascular outcomes in older adults
por: Chamberlin, Keran W., et al.
Publicado: (2023)

A Preliminary Study on the Value of Intestinal Flora in Predicting Major Adverse Cardiovascular and Cerebrovascular Events in Patients with Refractory Hypertension
por: Jiao, Jie, et al.
Publicado: (2022)

Adherence to Guideline‐Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial Disease
por: Armstrong, Ehrin J., et al.
Publicado: (2014)

Endothelial Dysfunction Is Associated With Major Adverse Cardiovascular Events in Peritoneal Dialysis Patients
por: Lee, Mi Jung, et al.
Publicado: (2014)

Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction
por: Zheng, Meifan, et al.
Publicado: (2020)

Genetic information improves the prediction of major adverse cardiovascular events in the GENEMACOR population
por: Mendonça, Maria Isabel, et al.
Publicado: (2021)

Cardiac rehabilitation performance predicts 1‐year major adverse cardiovascular events
por: Naami, Robert, et al.
Publicado: (2022)

Impact of Vaccination on Major Adverse Cardiovascular Events in Patients With COVID-19 Infection
por: Jiang, Joy, et al.
Publicado: (2023)

Necroptosis Drives Major Adverse Cardiovascular Events During Severe COVID-19
por: Wiscovitch-Russo, Rosana, et al.
Publicado: (2023)

Major adverse cardiovascular events are associated with necroptosis during severe COVID-19
por: Wiscovitch-Russo, Rosana, et al.
Publicado: (2023)

microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
por: de los Reyes-García, Ascensión M., et al.
Publicado: (2023)

IMPACT OF VACCINATION ON MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG PATIENTS WITH COVID-19
por: Jiang, Joy, et al.
Publicado: (2023)

Ten-year predictors of major adverse cardiovascular events in patients without angina
por: Premsagar, Preesha, et al.
Publicado: (2023)

Prognostic Value of Admission Mean Corpuscular Volume for Major Adverse Cardiovascular Events following Stent Implantation in Nondiabetic and Diabetic Patients with Acute Coronary Syndrome
por: Cheng, Lele, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ab459o3iosavgotpank56hj82s